Artisan Bio, Inc. announced it has entered into a global research and collaboration agreement with Takeda Pharmaceutical Company Limited for the discovery, development, and commercialization of novel cell therapy products. Under the terms of the agreement, Artisan Bio will deploy its STAR platform and synthetic biology expertise to construct customized and precisely engineered cell therapies. Artisan will lead discovery efforts, including gene editing, and Takeda will be responsible for the development, manufacturing, and commercialization of the resulting cell therapy products.